Search hospitals > Virginia > Fairfax
Fairfax Northern Virginia Hematology OnCology, PC
Claim this profileFairfax, Virginia 22031
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Solid Tumors
Conducts research for Lymphoma
21 reported clinical trials
2 medical researchers
Summary
Fairfax Northern Virginia Hematology OnCology, PC is a medical facility located in Fairfax, Virginia. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Adenocarcinoma, Solid Tumors, Lymphoma and other specialties. Fairfax Northern Virginia Hematology OnCology, PC is involved with conducting 21 clinical trials across 21 conditions. There are 2 research doctors associated with this hospital, such as Alexander Spira, MD and Mitul Gandhi.Area of expertise
1Non-Small Cell Lung Cancer
KRAS positive
Stage IV
Stage I
2Lung Cancer
Top PIs
Alexander Spira, MDVirginia Cancer Specialists2 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Tumors
123 reported clinical trials
165 drugs studied
Mitul GandhiVirginia Cancer Specialists5 years of reported clinical research
Studies Lymphoma
Studies Leukemia
17 reported clinical trials
31 drugs studied
Clinical Trials running at Fairfax Northern Virginia Hematology OnCology, PC
Follicular Lymphoma
Non-Small Cell Lung Cancer
Solid Tumors
Tumors
Adenocarcinoma
Pancreatic Adenocarcinoma
Colorectal Cancer
Lymphoma
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Fairfax Northern Virginia Hematology OnCology, PC?
Fairfax Northern Virginia Hematology OnCology, PC is a medical facility located in Fairfax, Virginia. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Adenocarcinoma, Solid Tumors, Lymphoma and other specialties. Fairfax Northern Virginia Hematology OnCology, PC is involved with conducting 21 clinical trials across 21 conditions. There are 2 research doctors associated with this hospital, such as Alexander Spira, MD and Mitul Gandhi.